At a glance
- Originator Bayer Schering Pharma
- Class Anxiolytics; Nootropics
- Mechanism of Action GABA A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease